Literature DB >> 16373621

HIV protease inhibitors and hyperlipidemia: a fatty acid connection.

Arthur A Spector.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16373621     DOI： 10.1161/01.ATV.0000198749.28422.29

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN： 1079-5642            Impact factor:   8.311


× No keyword cloud information.
  7 in total

1.  Prevention of HIV protease inhibitor-induced dysregulation of hepatic lipid metabolism by raltegravir via endoplasmic reticulum stress signaling pathways.

Authors:  Risheng Cao; Yiqiao Hu; Yun Wang; Emily C Gurley; Elaine J Studer; Xuan Wang; Phillip B Hylemon; William M Pandak; Arun J Sanyal; Luyong Zhang; Huiping Zhou
Journal:  J Pharmacol Exp Ther       Date:  2010-05-14       Impact factor: 4.030

2.  Development of a novel self-microemulsifying drug delivery system for reducing HIV protease inhibitor-induced intestinal epithelial barrier dysfunction.

Authors:  Bokai Lei; Weibin Zha; Yun Wang; Cong Wen; Elaine J Studer; Xuan Wang; Fang Jin; Guangji Wang; Luyong Zhang; Huiping Zhou
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

3.  Sequence-specific alterations of epitope production by HIV protease inhibitors.

Authors:  Georgio Kourjian; Yang Xu; Ijah Mondesire-Crump; Mariko Shimada; Pauline Gourdain; Sylvie Le Gall
Journal:  J Immunol       Date:  2014-03-10       Impact factor: 5.422

4.  Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages.

Authors:  Weibin Zha; Guang Liang; Jian Xiao; Elaine J Studer; Phillip B Hylemon; William M Pandak; Guangji Wang; Xiaokun Li; Huiping Zhou
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

5.  Resveratrol Co-Treatment Attenuates the Effects of HIV Protease Inhibitors on Rat Body Weight and Enhances Cardiac Mitochondrial Respiration.

Authors:  Burger Symington; Rudo F Mapanga; Gavin R Norton; M Faadiel Essop
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

6.  Plasma lipidomic profiling of treated HIV-positive individuals and the implications for cardiovascular risk prediction.

Authors:  Gerard Wong; Janine M Trevillyan; Benoit Fatou; Michelle Cinel; Jacquelyn M Weir; Jennifer F Hoy; Peter J Meikle
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

7.  Reduction of the HIV protease inhibitor-induced ER stress and inflammatory response by raltegravir in macrophages.

Authors:  Xiaoxuan Zhang; Risheng Cao; Runping Liu; Renping Zhao; Yi Huang; Emily C Gurley; Phillip B Hylemon; William M Pandak; Guangji Wang; Luyong Zhang; Xiaokun Li; Huiping Zhou
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.